Clinical Trials

Facioscapulohumeral muscular dystrophy

Displaying 2 studies

A Study to Evaluate Single DNA Molecule Optical Imaging to Diagnose Facioscapulohumeral Muscular Dystrophy (FSHD) Rochester, MN

The purpose of this study is to evaluate a novel direct single DNA molecule optical imaging system (Bionano) for the FSHD diagnosis.
Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) Rochester, MN

The purpose of this study is to evaluate the safety and effectiveness of losmapimod in treating patients with Facioscapulohumeral Muscular Dystrophy (FSHD) over 48 weeks.